| Cat.No. | Name | Information |
|---|---|---|
| M1825 | PCI-32765 | PCI-32765 (Ibrutinib) is a potent, selective and orally bioavailable irreversible inhibitor of BTK with IC50 value of 0.46 nM. |
| M6636 | CTA 056 | CTA 056 is a iTK inhibitor. |
| M5333 | Tirabrutinib | Tirabrutinib (ONO-4059) is a highly selective, orally bioavailable BTK inhibitor with a potency (IC50) of 2.2 nM. |
| M5306 | Acalabrutinib | Acalabrutinib(ACP-196) is a selective second-generation Bruton's tyrosine kinase (BTK) inhibitor, which prevents the activation of the B-cell antigen receptor (BCR) signaling pathway.BMX, and TEC, respectively) and no activity against EGFR. |
| M5257 | ONO-4059 hydrochloride | ONO-4059 (GS-4059) hydrochloride is highly potent and selective BTK inhibitor with an IC50 of 2.2 nM. |
| M5162 | ONO-4059 analogue | ONO-4059 analogue is the analog of ONO-4059, ONO-4059 is a highly potent and selective Btk inhibitor with IC50 of 23.9 nM. |
| M3704 | RN486 | RN486 is a Bruton's tyrosine kinase (Btk) inhibitor with an IC50 Value of 4.0 nM. |
| M3620 | CGI1746 | CGI1746 is a potent and highly selective small-molecule inhibitor of the Btk with IC50 of 1.9 nM. |
| M2718 | GDC-0834 | GDC-0834 is a novel potent and selective BTK inhibitor with IC50 of 5.9 nM. |
| M2536 | CNX-774 | CNX-774 is an irreversible, orally active, and highly selective BTK inhibitor with IC50 of <1 nM. |
| M2113 | Spebrutinib (AVL-292) | Spebrutinib (AVL-292) is an oral, potent and selective small molecule covalent inhibitor of Btk (IC50 < 0.5 nM). |
| M57190 | UBX-382 | UBX-382 is an orally available proteolysis-targeting chimeras (PROTACs) that target BTK to inactivate B-cell receptor signaling. |
| M57189 | GDC-0834 | GDC-0834 is a potent and selective BTK inhibitor. |
| M57188 | DD-03-171 | DD-03-171 is a BTK, IKFZ1 and IKFZ3 degrader, the BTK IC50 a value of 5.1 nM. |
| M57187 | N-piperidine Ibrutinib hydrochloride | N-piperidine Ibrutinib hydrochloride is a reversible Ibrutinib derivative. |
| M54669 | TL-925 | TL-925 is a potentially first-in-class Bruton's tyrosine kinase (BTK) inhibitor that targets mast cell-mediated ocular inflammation and hypersensitivity and can be used in studies related to dry eye. |
| M49783 | JAK3/BTK-IN-6 | JAK3/BTK-IN-6 is a potent BTK and JAK3 dual inhibitor, with IC50 values of 0.6 and 0.4 nM, respectively. |
| M43478 | DBt-10 | DBt-10 is a potent BTK degrader. |
| M43477 | BTK-IN-27 | BTK-IN-27 is a BTK inhibitor (IC50: 0.2 nM). |
| M43476 | NRX-0492 | NRX-0492 is an orally active and potent degrader of BTK. |
| M43475 | PROTAC BTK Degrader-5 | PROTAC BTK degraders-5is a selective BTK degrader with a DC50 value of 7.0 nM in JeKo-1 cells. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
